RNA激活(RNA activation, RNAa) 是一种由小分子RNA介导的特异性基因表达上调机制,是李龙承等[1]于2006年首先在人细胞中发现并命名的。随后,其他研究小组也报道了相似的现象,证明了RNA激活是从人及大小鼠等哺乳类动物到植物及线虫中的保守现象[2][3][4][5][6][7][8][9][10]。RNA激活是由靶向基因启动子区域的双链小RNA(dsRNA)分子介导并需要Argonaute(AGO)蛋白的参与[1][11]。这类能够诱导RNA激活现象(即激活基因表达)的dsRNA被称为小激活RNA(small activating RNA,saRNA)[12]。saRNA可通过人工设计及化学合成而获得,也可为天然存在的内源性RNA如miRNA;前者介导的RNA激活被称为外源性RNA激活,后者为内源性RNA激活。
介导外源性RNA激活的saRNA与介导RNAi的siRNA结构相似, 是含21个核苷酸的双链RNA(dsRNA),其兩条链在各自的3’端含2个核苷酸的突出。和RNAi一样,RNAa也需要AGO蛋白特别是AGO2的参与,其作用可能是处理和活化saRNA分子,并介导saRNA与其启动子上的靶位点结合。与RNAi(主要发生在胞浆)不同的是,RNA激活机制发生在细胞核,介导RNA激活的saRNA靶向启动子而不是mRNA序列,此外,RNA激活具有特殊的时效性,表现为其效果(基因表达上调)的出现呈现48小时左右的滞后,及效果的长久性(10-14天)[1][13][14]。其机制被认为是因为RNA激活导致了表观遗传的改变[15]。
2008年Place等[16]报道了天然存在的miRNA也能够靶向启动子序列而诱导RNA激活。他们发现人CDH1及CSDC2基因启动子存在miR-373的靶位点,在人肿瘤细胞中引入miR-373的模拟物(mimics)能激活其靶基因的表达。后来,Huang等进一步证实了内源性miRNA介导的RNAa,并且发现该机制在正常及肿瘤细胞的增殖中起重要作用[17]。Xiao等还报道了靶向增强子区域的miRNA也能够诱导RNA激活[18]。Chaluvally-Raghavan等发现miR-551b-3p通过靶向激活STAT3而促进卵巢癌细胞增殖、生存和肿瘤生长[19]。目前对于有多少基因受到内源性RNA激活机制的调控还不清楚,但有研究发现miRNA[20]及AGO蛋白[21]在人基因组的启动子区存在广泛的结合位点,提示miRNA可能在转录或者表观遗传水平调控大量的基因。
RNA激活是一种简单易行的上调基因表达的方法,在生物医学领域具有广泛的潜在用途,包括作为工具用于研究基因的功能[22]和对细胞进行重新编程[23][24][25][26],以及作为治疗疾病的手段,包括肿瘤、心血管疾病、勃起功能障碍等[27][28][29][30][31][32]。目前,治疗肝癌的saRNA药已经进入临床试验[28]。
Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol. March 2007, 3 (3): 166–73. PMID 17259978. doi:10.1038/nchembio860.
Reebye, Vikash; Sætrom, Pål; Mintz, Paul J.; Huang, Kai-Wen; Swiderski, Piotr; Peng, Ling; Liu, Cheng; Liu, Xiaoxuan; Lindkaer-Jensen, Steen. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology (Baltimore, Md.). 2014-1, 59 (1): 216–227 [2018-08-20]. ISSN 1527-3350. PMC 4655108 . PMID 23929703. doi:10.1002/hep.26669. (原始内容存档于2018-08-20).
Chaluvally-Raghavan, Pradeep; Jeong, Kang Jin; Pradeep, Sunila; Silva, Andreia Machado; Yu, Shuangxing; Liu, Wenbin; Moss, Tyler; Rodriguez-Aguayo, Cristian; Zhang, Dong. Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Reports. 2016-05-17, 15 (7): 1493–1504 [2018-08-20]. ISSN 2211-1247. PMC 4914391 . PMID 27160903. doi:10.1016/j.celrep.2016.04.034. (原始内容存档于2018-08-20).
Paugh, Steven W.; Coss, David R.; Bao, Ju; Laudermilk, Lucas T.; Grace, Christy R.; Ferreira, Antonio M.; Waddell, M. Brett; Ridout, Granger; Naeve, Deanna. MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene Expression. PLoS computational biology. 2016-2, 12 (2): e1004744 [2018-08-20]. ISSN 1553-7358. PMC 4742280 . PMID 26844769. doi:10.1371/journal.pcbi.1004744. (原始内容存档于2018-08-20).
Reebye, Vikash; Sætrom, Pål; Mintz, Paul J.; Rossi, John J.; Kasahara, Noriyuki; Nteliopoulos, Georgios; Nicholls, Joanna; Haoudi, Abdelali; Gordon, Myrtle. A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells. Molecular Therapy. Nucleic Acids. 2013-06-04, 2: e97 [2018-08-20]. ISSN 2162-2531. PMC 3696904 . PMID 23736775. doi:10.1038/mtna.2013.23. (原始内容存档于2018-08-20).
Voutila, Jon; Reebye, Vikash; Roberts, Thomas C.; Protopapa, Pantelitsa; Andrikakou, Pinelopi; Blakey, David C.; Habib, Robert; Huber, Hans; Saetrom, Pal. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2017-12-06, 25 (12): 2705–2714 [2018-08-20]. ISSN 1525-0024. PMC 5768526 . PMID 28882451. doi:10.1016/j.ymthe.2017.07.018. (原始内容存档于2018-08-20).
Turunen, Mikko P.; Lehtola, Tiia; Heinonen, Suvi E.; Assefa, Genet S.; Korpisalo, Petra; Girnary, Roseanne; Glass, Christopher K.; Väisänen, Sami; Ylä-Herttuala, Seppo. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circulation Research. 2009-09-11, 105 (6): 604–609 [2018-08-20]. ISSN 1524-4571. PMID 19696410. doi:10.1161/CIRCRESAHA.109.200774. (原始内容存档于2018-08-20).
Turunen, Mikko P.; Husso, Tiia; Musthafa, Haja; Laidinen, Svetlana; Dragneva, Galina; Laham-Karam, Nihay; Honkanen, Sanna; Paakinaho, Anne; Laakkonen, Johanna P. Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice. PloS One. 2014, 9 (2): e89979 [2018-08-20]. ISSN 1932-6203. PMC 3935957 . PMID 24587164. doi:10.1371/journal.pone.0089979. (原始内容存档于2018-08-21).